Talita Carolina Bragança de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Talita Carolina Bragança de Oliveira has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Hellmeister de Campos Nogueira Romaldini
Instituto Biológico de São Paulo, Brazil
1 shared publication - Andresa Xavier Frade Gomes
Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), Câmpus de Botucatu, Botucatu-SP, Brazil
1 shared publication - Bárbara Braga Ferreira Marta
Universidade Estadual Paulista (UNESP), Faculdade de Medicina Veterinária, Rua Clóvis Pestana, 793, Araçatuba, São Paulo 16050-680, SP, Brazil
1 shared publication - Carolina Beatriz Baptista
São Paulo State University (Unesp), School of Veterinary Medicine, Araçatuba, Brazil
1 shared publication - Debora Regina Romualdo da Silva
Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Rd., North Grafton, MA 01536, USA
1 shared publication - Fernanda Senter Magajevski
Centro de Reabilitação de Animais Silvestres – CRAS
1 shared publication
Latest Publications
- Open Access
- 2 August 2024
- Published by Universidade Federal Rural de Pernambuco in Medicina Veterinária (UFRPE)
- Vol. 18 (2) , 159-168
ANTIBODIES AGAINST Leptospira spp. IN DAIRY CATTLE IN A FAMILY AGRICULTURE SYSTEM
Leptospirosis is an endemic zoonosis in Brazil responsible for numerous reproductive and economic losses to the dairy industry. Brazil ranks fifth in the world's production of cow's milk and around 23 million cows are milked every day. The northwest region of the state of São Paulo has a considerable number of family farming settlements, with dairy farming being predominant. This article reports a seroepidemiological study to detect agglutinins against Leptospira spp. in 1,004 dairy cattle kept on 64 family farms producing milk in the northwest region of São Paulo. Management and environmental data for situation diagnosis were obtained with a questionnaire. Antibodies against Leptospira spp. were investigated by the microscopic seroagglutination test (SAM) and milk and urine samples were obtained from seroreactive animals with titer ? 400. These samples were submitted to molecular tests. Of the 64 properties studied, 63 (98%) had seroreactive animals. Of the 1,004 animals, 523 (52%) were reactive. According to the molecular tests, the presence of Leptospira spp. in the urine and milk of the seroreactive animals was negative. Wetlands, presence of rodents, occurrence of abortion, presence of dogs, presence of cats and presence of horses were variables associated with the risk of infection by Leptospira spp. In addition to its importance in animal health, leptospirosis poses a risk to human health, a situation that indicates the need for improvement of sanitary conditions in rural properties.
- 2 August 2024
- Published by Universidade Federal Rural de Pernambuco in Medicina Veterinária (UFRPE)
- Vol. 18 (2) , 159-168
Open AccessANTIBODIES AGAINST Leptospira spp. IN DAIRY CATTLE IN A FAMILY AGRICULTURE SYSTEM
Leptospirosis is an endemic zoonosis in Brazil responsible for numerous reproductive and economic losses to the dairy industry. Brazil ranks fifth in the world's production of cow's milk and around 23 million cows are milked every day. The northwest region of the state of São Paulo has a considerable number of family farming settlements, with dairy farming being predominant. This article reports a seroepidemiological study to detect agglutinins against Leptospira spp. in 1,004 dairy cattle kept on 64 family farms producing milk in the northwest region of São Paulo. Management and environmental data for situation diagnosis were obtained with a questionnaire. Antibodies against Leptospira spp. were investigated by the microscopic seroagglutination test (SAM) and milk and urine samples were obtained from seroreactive animals with titer ? 400. These samples were submitted to molecular tests. Of the 64 properties studied, 63 (98%) had seroreactive animals. Of the 1,004 animals, 523 (52%) were reactive. According to the molecular tests, the presence of Leptospira spp. in the urine and milk of the seroreactive animals was negative. Wetlands, presence of rodents, occurrence of abortion, presence of dogs, presence of cats and presence of horses were variables associated with the risk of infection by Leptospira spp. In addition to its importance in animal health, leptospirosis poses a risk to human health, a situation that indicates the need for improvement of sanitary conditions in rural properties.
- Open Access
- 17 May 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (6)
Vaccine development for cryptosporidiosis: Systematic review
Cryptosporidium spp. are opportunistic parasites with zoonotic potential transmitted by ingestion of contaminated water and food, the infection consists of severe diarrhea leading to the death of babies and immunocompromised individuals. In the veterinary, it can generate economic losses due to the death of calves, these animals being a possible source of transmission of the parasite. Nitazoxanide and halofuginone are the only drugs approved for treatment in humans and calves respectively, however there are restrictions on their use. There is still no vaccine against cryptosporidiosis in humans or animals and its development is a great challenge. Our objective with the present work was to write a systematic review of the literature addressing the progress of studies on vaccines against cryptosporidiosis. The recommended guidelines for RSL were used, with the aid of the StArt software (State of the Art through Systematic Rewiews). The research took place in the databases: Lilacs, PubMed, Scielo, Science Direct, Scopus, Embase and Medline. In 30% of the selected articles, the calves were the study animal and in 50% the mice; 40% of the studies were with vaccines derived from recombinant proteins and 30% of the research was aimed at inhibiting the parasite from entering cells and activating the host's protective immunity. So far, a vaccine with no proven efficacy or an ideal cost-benefit has been developed. Many candidate antigenic targets for a vaccine have been characterized, in addition to elucidating the immunogenicity mechanism of Cryptosporidium spp. in the infected individual. However, another antigenic targets for a vaccine can be searched in future studies.
- 17 May 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (6)
Open AccessVaccine development for cryptosporidiosis: Systematic review
Cryptosporidium spp. are opportunistic parasites with zoonotic potential transmitted by ingestion of contaminated water and food, the infection consists of severe diarrhea leading to the death of babies and immunocompromised individuals. In the veterinary, it can generate economic losses due to the death of calves, these animals being a possible source of transmission of the parasite. Nitazoxanide and halofuginone are the only drugs approved for treatment in humans and calves respectively, however there are restrictions on their use. There is still no vaccine against cryptosporidiosis in humans or animals and its development is a great challenge. Our objective with the present work was to write a systematic review of the literature addressing the progress of studies on vaccines against cryptosporidiosis. The recommended guidelines for RSL were used, with the aid of the StArt software (State of the Art through Systematic Rewiews). The research took place in the databases: Lilacs, PubMed, Scielo, Science Direct, Scopus, Embase and Medline. In 30% of the selected articles, the calves were the study animal and in 50% the mice; 40% of the studies were with vaccines derived from recombinant proteins and 30% of the research was aimed at inhibiting the parasite from entering cells and activating the host's protective immunity. So far, a vaccine with no proven efficacy or an ideal cost-benefit has been developed. Many candidate antigenic targets for a vaccine have been characterized, in addition to elucidating the immunogenicity mechanism of Cryptosporidium spp. in the infected individual. However, another antigenic targets for a vaccine can be searched in future studies.